Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
February 5, 2026
Approximately 5 minutes
CE Marking Process for Medical Devices in the EU and Denmark
CE Marking Process for Medical Devices in the EU and Denmark
1. Purpose of CE Marking
CE marking documents that a medical device complies with applicable EU legislation, allowing free marketing within the EU provided national requirements (e.g., registration and language) are met. It is required when the device is first made available for distribution or use, whether new, refurbished, free, or paid. Custom-made devices, systems/procedure packs, and investigational devices are exempt from CE marking. Source: Danish Medicines Agency CE Marking Page https://laegemiddelstyrelsen.dk/en/devices/ce-marking/
2. Achieving CE Marking
To obtain CE marking:
- Confirm the product meets the medical device definition.
- Classify correctly per Annex VIII rules (classes I-III for general devices; A-D for IVDs, with I/A lowest risk and III/D highest).
- Follow the appropriate conformity assessment procedure. For Class I/A devices, manufacturers self-certify. Higher classes require notified body certification. Source: Danish Medicines Agency CE Marking Page https://laegemiddelstyrelsen.dk/en/devices/ce-marking/
3. Role of Notified Bodies
Notified bodies, designated by authorities, assess technical documentation and quality systems for higher-risk devices. Manufacturers may choose any notified body. Source: Danish Medicines Agency CE Marking Page https://laegemiddelstyrelsen.dk/en/devices/ce-marking/
4. Technical Documentation and Clinical Evaluation
Documentation must address Annex I general safety and performance requirements, including ongoing clinical evaluation analysing data from sources like literature and own studies. The core is risk analysis, assessing acceptability of risks versus benefits, updated continuously. Source: Danish Medicines Agency CE Marking Page https://laegemiddelstyrelsen.dk/en/devices/ce-marking/
5. Declaration of Conformity
After meeting requirements and preparing documentation, the manufacturer signs and retains a declaration of conformity. This, along with technical documentation, must be available to the Danish Medicines Agency for at least 10 years (non-implantable/IVDs) or 15 years (implantable) after last manufacture. Source: Danish Medicines Agency CE Marking Page https://laegemiddelstyrelsen.dk/en/devices/ce-marking/
6. Affixing the CE Mark
The CE mark is affixed visibly, legibly, and indelibly to the device, packaging, and instructions for use (per Annex V model). For devices involving a notified body, include its identification number. For sterile devices, place on the sterility-maintaining package. Source: Danish Medicines Agency CE Marking Page https://laegemiddelstyrelsen.dk/en/devices/ce-marking/
7. Legislation
- Regulation (EU) 2017/745 on medical devices (MDR)
- Regulation on in vitro diagnostic medical devices (IVDR)
- Danish executive order no. 957 of 29 April 2021 Source: Danish Medicines Agency CE Marking Page https://laegemiddelstyrelsen.dk/en/devices/ce-marking/
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Danish Medicines Agency Guidance for Medical Device Development
The Danish Medicines Agency provides practical guidance for manufacturers developing medical devices, covering classification, conformity assessment, clinical evaluation, quality management, and post-market surveillance under EU MDR.
Approximately 5 minutes
Danish Medicines Agency Regulatory Advice for Medical Device Companies
The Danish Medicines Agency offers free regulatory advice meetings for startups, SMEs, and research units on EU MDR/IVDR requirements, including CE marking and clinical investigations, but excludes device classification and approvals.
Approximately 5 minutes
Notified Bodies for Medical Devices: Role and Oversight in Denmark
Notified bodies assess conformity for higher-risk medical devices under EU MDR/IVDR; in Denmark, the Medicines Agency supervises but no local bodies are designated—manufacturers select from EU-wide NANDO list.